A Cardiac Resynchronization Therapy Defibrillator (CRT-D) Related Image
(Not Necessarily related to the device)
Description:
CONTAK RENEWAL by Boston Scientific Corp.
The CONTAK RENEWAL is an advanced cardiac resynchronization therapy defibrillator (CRT-D) developed by eminent medical manufacturer, Boston Scientific Corp. This state-of-the-art device is designed to monitor and control heart rhythm in patients with heart disease, combining cardiac resynchronization and defibrillatory therapies in a single unit.
Specifically, the CONTAK RENEWAL provides multi-site pacing and bi-ventricular pacing capabilities. This flexibility allows it to deliver therapy tailored to the individual patient's condition and needs. The device boasts high-energy defibrillation shocks for urgent cardiac events, alongside lower energy pacing impulses for the routine management of arrhythmias.
Key benefits of the CONTAK RENEWAL include its potential to improve exercise capacity, decrease heart failure hospitalizations, and enhance overall quality of life for its patients. Furthermore, the device is MRI compatible, providing safe and uninhibited access to important diagnostic procedures. With an impressive device longevity, the CONTAK RENEWAL ensures reliable performance over an extended service life.
With Boston Scientific's reputation for innovation and patient-focused design, the CONTAK RENEWAL represents a significant forward stride in cardiac care, providing clinicians with a powerful combination of technology and adaptability to customize treatments to patient needs.
Primary Use:
CONTAK RENEWAL: A Primary Device in Pacemaker Technology
Background CONTAK RENEWAL is a crucial tool in our arsenal of medical equipment, particularly in treating potentially life-threatening heart conditions. It is an advanced cardiac resynchronization therapy defibrillator, or CRT-D, that goes beyond simply regulating heart rhythms.
Primary Medical Use
At its core, the CONTAK RENEWAL serves a dual role: Its primary functions are to provide cardiac resynchronization therapy (CRT) and automated defibrillation.
CRT is a therapeutic treatment for patients who suffer from heart failure with reduced ejection fraction and a delayed electrical system. This delay, also known as dyssynchrony, leads to an inefficient contraction of the
How It Works:
Introduction to CONTAK RENEWAL Pacemakers
The CONTAK RENEWAL is an advanced device under the category of Cardiac Resynchronization Therapy Pacemakers (CRT-Ps). This implantable, multi-chamber device is designed to address cardiac dyssynchrony.
How CONTAK RENEWAL Works
The CONTAK RENEWAL works by rectifying induced electrical disturbances within the heart's chambers. The device essentially administers electric currents as corrective stimuli and triggers the cardiac muscles into appropriate rhythm and synchronization.
Upon detection of any irregular or abnormal heartbeat, the “Pacemaker” springs into action. The primary function is to restore and maintain normal heart rhythm by releasing electric signals to regulate the heart's pumping action.
Conducting the Therapy
The operation of the CONTAK RENEWAL is twofold. It first performs the role of a regular pacemaker by correcting bradycardia (slow heart rhythms). However, when the heart beats irregularly or out of sync, the device employs cardiac resynchronization therapy. It releases tiny impulses to stimulate both the left and right ventricles, thus ensuring they contract simultaneously, preserving the efficiency of the heart's function.
Defibrillator Mechanism
Further, the CONTAK RENEWAL has an automatic, built-in Implantable Cardioverter-Defibrillators (ICDs) which is activated when ventricular arrhythmias - excessively rapid heart rhythms - are detected. The ICD releases signals potent enough to restore the normal heart rhythm.
In Summary
Boasting advanced cardiac control features, the CONTAK RENEWAL pacemaker is an innovative tool designed to ensure optimal synchrony in the cardiac function. Its unique capability to adapt to both slow and rapid abnormal heart rhythms makes it an indispensable piece of equipment for numerous medical practitioners and cardiologists alike. The adaptive technology within the device offers patient-tailored therapeutic precision, ensuring improved treatment outcome and enhanced quality of life for patients experiencing cardiac dyssynchrony.
Manufacturer:
Boston Scientific Corp.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.